微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 43.62% | 15.95% | 1.69% | 88/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 42.89% | 56.78% | 5.15% | 88/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 40.79% | 28.52% | -2.02% | 89/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 41.64% | 20.02% | 10.68% | 87/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 37.62% | 5.64% | 37.5% | 97/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 27.36% | -15.43% | -13.8% | 112/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 31.74% | -26.2% | -8.51% | 111/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 34.69% | -6.58% | -2.58% | 105/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 35.61% | 0.4% | 10.08% | 106/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 32.35% | -1.16% | -24.78% | 103/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 43.01% | -15.32% | 15.82% | 90/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 37.14% | -33.15% | 4.7% | 97/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 35.47% | -38.26% | 8.36% | 102/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 32.73% | -48.51% | -35.56% | 104/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 50.79% | -31.16% | -8.56% | 79/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 55.55% | -27.87% | -3.29% | 67/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 57.44% | -26.88% | -9.65% | 66/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 63.57% | -15.59% | -13.84% | 50/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 73.79% | -6.88% | -4.19% | 25/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 77.01% | -7.25% | -1.97% | 17/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 78.56% | -5.09% | 4.3% | 17/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 75.32% | 19.09% | -4.95% | 21/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 79.24% | 66.81% | -4.57% | 18/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 83.03% | 76.65% | 0.31% | 10/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 82.77% | 76.84% | 30.88% | 13/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 63.24% | 2% | 33.13% | 35/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 47.51% | -2.39% | 1.06% | 76/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 47.01% | 2% | 0.42% | 38/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 46.81% | 2% | -3.83% | 47/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 48.67% | 1.14% | 1.14% | 67/141 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2017-12-31 | 48.12% | 2% | 2% | 64/141 | 56.1% | 正海生物 | 93.08% | 行业排名> |